- Adenovirus Type 2.
- Echovirus Type 11.
- Enterovirus Type 71.
- Human Rotavirus.
- Norovirus.
- Adenovirus Type 5.
- Rhinovirus Type 1A.
- Candida auris
- Penicillin-Resistant Streptococcus pneumoniae (PRSP).
- Vancomycin-Resistant Enterococcus faecalis (VRE).
- Methicillin-Resistant Staphylococcus aureus (MRSA).
- Carbapenem-resistant Klebsiella pneumoniae (CRKP).
- Multidrug-Resistant Acinetobacter baumannii (MRAB).
- NDM-1 Enterobacter cloacae.
- Vancomycin-Intermediate Staphylococcus aureus (VISA).
- Methicillin-Resistant Staphylococcus epidermidis.
- Multi-Drug Resistant Pseudomonas aeruginosa.
- ESBL Klebsiella pneumoniae.
- ESBL Escherichia coli.
- Acinetobacter baumannii.
- Bordetella pertussis.
- Burkholderia cepacia.
- Enterococcus faecium.
- Escherichia coli O157:H7.
- Klebsiella pneumoniae.
- Legionella pneumophila.
- Micrococcus luteus.
- Moraxella catarrhalis.
- Pseudomonas aeruginosa.
- Salmonella enterica.
- Staphylococcus aureus.
- Stenotrophomonas maltophilia.
- Streptococcus mutans.
- Streptococcus pyogenes.
- Klebsiella aerogenes.
- Serratia marcescens.
- Campylobacter jejuni.
- Listeria monocytogenes.
- Shigella dysenteriae.
- Chlamydophila pneumoniae.
- Flavobacterium columnare.
- Mycobacterium tuberculosis (TB).
- Herpes simplex virus Type 1.
- Herpes simplex virus Type 2.
- lnfluenza A virus.
- Varicella-zoster virus.
- Cytomegalovirus.
- SARS-associated Coronavirus.
- SARS-CoV-2.
- SARS-CoV-2 – UK Variant.
- SARS-CoV-2 – South African Variant.
- SARs-CoV-2 – California Variant.
- SARS-CoV-2 – Delta Variant.
- lnfluenza B virus.
- Parainfluenza virus Type 3.
- Human orthopneumovirus.
- Measles virus.
- Hepatitis C Virus (HCV).
- Hepatitis B Virus (HBV).
- Human lmmunodeficiency Virus Type 1 (HIV-1).
- Ambulance equipment surfaces.
- Animal care facilities.
- Bathrooms.
- Correctional facilities.
- Daycare centers.
- Dental offices.
- Emergency medical settings.
- Emergency vehicles.
- Exterior surfaces of anesthesia machines and respiratory therapy equipment.
- Health club facilities.
- Hospitals.
- Infant/child care equipment surfaces.
- Interior and exterior surfaces of infant incubators, bassinets.
- Isolation areas.
- Laboratories.
- Laundry rooms.
- Neonatal units.
- Nursing homes.
- Operating rooms.
- Ophthalmic and optometric facilities.
- Outpatient surgical centers.
- Oxygen hoods.
- Schools.
- Surgical centers.
- 12 Canisters of 160 CaviWipes 2.0 Disinfecting Wipes (Size 6" x 6.75").
- 12 Canisters of 65 CaviWipes 2.0 Disinfecting Wipes (Size 9" x 12").
- Proven effective against SARS-CoV-2 on hard non-porous surfaces.
- On EPA List Q.
- Qualifies for the EPA’s Emerging Viral Pathogens claim for all virus types (enveloped, large and small non-enveloped viruses) to meet current and potentially future infection prevention needs.
- Enhanced Efficacy Claims - Effective against 60 relevant pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
- Excellent Material Compatibility - Compatible with most non-porous, hard surfaces commonly used in clinical settings.
- Easy to use label - Makes it quick and easy to find critical information on efficacy, compatibility, and more.
- 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris).
Product Specifications
| Manufacturer Part 14-1100: | Size 6" x 6.75" |
|---|---|
| Manufacturer Part 14-1150: | Size 9" x 12" |
| Country of Origin: | USA |
| Active Ingredients: | Isopropyl Alcohol / Proprietary Glycol Ether |
| Container Type: | Canister |
| EPA Registration Number: | 46781-17 |
|---|---|
| Scent: | Alcohol Scent |
| Sterility: | Non-Sterile |
| UNSPSC Code: | 47131502 |